As at 4 January 2018, we had recommended 27 different ASX and Global stocks in our Trident Confidential Growth Portfolio. Below is a list of the unrealised profits as at 4 January 2018.

Almost all of the stocks shown below are still current recommendations in some of our reports as we believe that they still have substantial potential over coming years.

Past performance is not a reliable indicator of future performance and you should also ensure that these investments are suitable for your needs and risk profile.

Current and Recent Recommendations

 

Company

Bought in

Profit or Loss

 

Healthcare

Oct-17

9.77%

 

Financial

Jul-17

17.21%

 

Technology

Jul-17

21.74%

 

Financial

Jul-17

13.91%

 

Industrials

Jul-17

4.82%

 

Healthcare

Dec-16

40.53%

 

Healthcare

Nov-16

39.57%

 

Technology

Sep-16

30.25%

 

Technology

Aug-16

221.27%

 

Internet

Jul-16

60.04%

 

Healthcare

Apr-16

71.96%

 

Healthcare

Mar-16

23.53%

 

Communications

Mar-16

15.26%

 

Financial

Feb-16

73.52%

 

Technology

Feb-16

183.44%

 

Financial

Feb-16

58.43%

 

Industrials

Feb-16

33.02%

 

Technology

Feb-16

60.94%

 

Industrials

Feb-16

41.20%

 

Financial

Jan-16

80.89%

 

Industrials

Jan-16

38.58%

 

Consumer

Jan-16

82.15%

 

Technology

Aug-15

138.40%

 

Financial

Jan-15

119.53%

 

Financial

Apr-14

129.62%

 

Technology

Oct-11

329.59%

 

Technology

Oct-11

326.29%

 

Open positions average return

 

83.91%

 

Previously our Performance Page was updated as at 12 July 2017, where we had listed our recommended 24 stocks in our Trident Confidential Growth Portfolio. 

The average return then was 67.46%. The last 6 months has seen the portfolio rise 16.45% which includes purchases made during the last 6 months (5 stocks).